Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. - Wikidata - wikimedia - TriplyDB

Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.

Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.

http://www.wikidata.org/entity/Q30451936

about

Psychosexual disorders and dermatologists Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.Advances in pharmacotherapy for treating female sexual dysfunction.Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.A review of antidepressant therapy in primary care: current practices and future directions.Testosterone supplementation for hypoactive sexual desire disorder in women.Commentary on "Critical flaws in the FSFI and IIEF"."The Pleasure Is Better as I've Gotten Older": Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV.The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.

P2860

Q26746754-9CFD4077-FA68-4B9B-9854-91D4B6BB57AC Q34336933-A6828A60-C544-4C86-9BB3-B82927DA4BA3 Q34465301-C9FE3A89-00ED-407B-A850-065DA802C133 Q36655856-F525FD21-86AC-49BA-A6F2-AE987BE44B09 Q37070398-5CE6FB99-95BC-4DD2-977D-D39499A6876E Q37990887-C6C11382-7D43-4A4C-B337-E3615E554558 Q38211669-F71682B3-CD51-4459-B247-AD39DF83BC80 Q39739692-5D8D5885-79DC-47E7-96E3-7F29073B696D Q42647545-9E3326A3-044E-4B7D-AABF-D3FC8462A4C1

P2860

Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.

http://www.wikidata.org/entity/Q30451936

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Flibanserin: a potential treat ...... sorder in premenopausal women.

@ast

Flibanserin: a potential treat ...... sorder in premenopausal women.

@en

type

label

Flibanserin: a potential treat ...... sorder in premenopausal women.

@ast

Flibanserin: a potential treat ...... sorder in premenopausal women.

@en

prefLabel

Flibanserin: a potential treat ...... sorder in premenopausal women.

@ast

Flibanserin: a potential treat ...... sorder in premenopausal women.

@en

P1433

Q30451936-4509B1D0-B05D-49CA-A41A-B0959A3D7CE4

P1476

Q30451936-71DADEFC-DBD4-4B74-B367-EA4DD3A0CD98

P2093

Q30451936-0445C2CD-48FE-4FD6-B3EF-6310E28D0302

Q30451936-85C19842-BE0F-4E7F-BB3C-91918C4A0E4A

Q30451936-978A83D6-1F4B-498B-BC0F-BE911A6AA96B

Q30451936-993295EE-4EB7-4E5A-A3B2-7680F639D5E7

P2860

Q30451936-004E4A55-6997-4B90-BFA9-7A2D4D0355D7

Q30451936-0D3E9205-1230-40DA-AE98-E85610873BDD

Q30451936-0DD2CDDD-312C-438F-8A92-2DF132AB1743

Q30451936-2CEA9FD0-1D61-4D9A-9E37-D1D0FC80B247

Q30451936-4B9D846E-DBD3-437C-AD3E-78653DC778B8

Q30451936-4DAC3F11-03F5-43AA-8075-3E9CCF226C39

Q30451936-567BECBE-5F40-4973-BBA4-FB1AE474D500

Q30451936-59F4CE84-DD38-46E6-BDC6-A4B380C099BC

Q30451936-5D9D9E85-E5E1-4781-A0E8-0A5FFC771886

Q30451936-5FD6F235-B590-41F8-AB5E-1DFC2A1D9EBC

P304

Q30451936-79E13F02-7DA2-4485-9B52-D646D5488403

P31

Q30451936-BF486A62-E511-4202-AFAA-5F88F47E902D

P356

Q30451936-EAC166D1-F108-485C-A2DB-C11A9279B0A6

P433

Q30451936-D7166FD8-37BB-492A-98A0-B8E5B52C0CE1

P478

Q30451936-F6F7C66B-E30A-4AC4-BACB-649FD329C04D

P577

Q30451936-F2BCEC52-2103-42EE-B75F-E6A9B7C6C913

P698

Q30451936-560DC9A9-E9BF-4F1C-BB05-0F36D0EB098B

P356

P1433

P1476

Flibanserin: a potential treat ...... sorder in premenopausal women.

@en

P2093

A H Clayton

http://www.w3.org/2001/XMLSchema#string

L Dennerstein

http://www.w3.org/2001/XMLSchema#string

M Sand

http://www.w3.org/2001/XMLSchema#string

R Pyke

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain

Pharmacology of flibanserin

Pathways of sexual desire

Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study

Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD).

Standards for clinical trials in sexual dysfunction in women: research designs and outcomes assessment.

The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.

Evaluation of a cognitive behavior therapy program for people with sexual dysfunction.

Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.

P304

639-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/WHE.10.54

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20887163

http://www.w3.org/2001/XMLSchema#string